Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-25 @ 2:04 PM
Study NCT ID:
NCT02924766
Status:
COMPLETED
Last Update Posted:
2020-07-20
First Post:
2016-10-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-19
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-04
First Submit QC Date:
None
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-16
Last Update Post Date:
2020-07-20
Last Update Post Date Type:
ACTUAL